Table 4.
Ordinal logistic regression analyses of Any HPV, HR-HPV, Vaccine-protected HR-HPV, and Vaccine-unprotected HR-HPV detection (persistent detection vs. incidence detection vs. no detection) with plasma AFB1-lys detection and demographic/behavioral characteristics of women5.
| Any HPV1 | HR-HPV2 | Vaccine-protected HR-HPV3 | Vaccine-unprotected HR-HPV4 | |||||
|---|---|---|---|---|---|---|---|---|
| Plasma AFB1-lys detection | 3.03 (1.088.55) | 0.036 | 3.63 (1.3010.13) | 0.014 | 1.55 (0.54–4.44) | 0.413 | 4.46 (1.13–17.58) | 0.032 |
| Age | 0.88 (0.79–0.98) | 0.017 | 0.92 (0.83–1.02) | 0.127 | 0.93 (0.83–1.03) | 0.180 | 0.91 (0.79–1.05) | 0.188 |
| Married | 0.28 (0.08–0.94) | 0.039 | 0.63 (0.20–2.03) | 0.442 | 0.38 (0.11–1.32) | 0.128 | 0.58 (0.15–2.28) | 0.437 |
| More than secondary school education | 1.13 (0.27–4.76) | 0.868 | 0.72 (0.17–2.95) | 0.645 | 1.41 (0.33–5.98) | 0.643 | 1.10 (0.17–6.98) | 0.918 |
| Home ownership | 2.43 (0.71–8.31) | 0.156 | 1.60 (0.48–5.30) | 0.441 | 1.45 (0.41–5.18) | 0.563 | 1.78 (0.38–8.34) | 0.465 |
| Walking distance to health care ≥ 60 mins | 1.46 (0.27–7.77) | 0.657 | 0.83 (0.16–4.18) | 0.820 | 0.46 (0.08–2.74) | 0.397 | 2.27 (0.36–14.06) | 0.380 |
| Number of lifetime sex partners | 1.07 (0.86–1.34) | 0.544 | 1.10 (0.88–1.36) | 0.405 | 1.02 (0.81–1.29) | 0.880 | 0.99 (0.77–1.27) | 0.918 |
| Age of first sex | 1.16 (0.98–1.38) | 0.088 | 1.08 (0.92–1.28) | 0.351 | 1.18 (0.99–1.40) | 0.066 | 0.74 (0.57–0.97) | 0.031 |
Any HPV: HPV 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 64, 66, 67, 68, 70, 71, 72, 73, 81, 82, 83, 84, CP6108, IS39
HR-HPV (High-Risk HPV): HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 67, 68, 69, 70, 73, 82, IS39
Vaccine-protected HR-HPV: HPV 16, 18, 31, 33, 45, 52, 58
Vaccine-unprotected HR-HPV: HPV 26, 35, 39, 51, 53, 56, 59, 66, 67, 68, 69, 70, 73, 82, IS39